Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-172227
Filing Date
2024-06-28
Accepted
2024-06-28 16:03:33
Documents
8
Effectiveness Date
2024-06-28

Document Format Files

Seq Description Document Type Size
1 S-8 d623076ds8.htm S-8 63668
2 EX-5.1 d623076dex51.htm EX-5.1 8586
3 EX-23.1 d623076dex231.htm EX-23.1 1597
4 EX-99.1 d623076dex991.htm EX-99.1 160122
5 EX-99.2 d623076dex992.htm EX-99.2 51880
6 EX-99.3 d623076dex993.htm EX-99.3 30834
7 EX-FILING FEES d623076dexfilingfees.htm EX-FILING FEES 20842
8 GRAPHIC g623076623076.jpg GRAPHIC 7100
  Complete submission text file 0001193125-24-172227.txt   348606
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280567 | Film No.: 241085550
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)